- Home
- EVTL vs LXRX Comparison
EVTL vs LXRX Comparison
Compare EVTL & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVTL
- LXRX
- Stock Information
- Founded
- EVTL 2016
- LXRX 1995
- Country
- EVTL United Kingdom
- LXRX United States
- Employees
- EVTL N/A
- LXRX N/A
- Industry
- EVTL Aerospace
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- EVTL Industrials
- LXRX Health Care
- Exchange
- EVTL Nasdaq
- LXRX Nasdaq
- Market Cap
- EVTL 467.9M
- LXRX 428.8M
- IPO Year
- EVTL N/A
- LXRX 2000
- Fundamental
- Price
- EVTL $4.85
- LXRX $1.10
- Analyst Decision
- EVTL Strong Buy
- LXRX Buy
- Analyst Count
- EVTL 7
- LXRX 5
- Target Price
- EVTL $10.83
- LXRX $3.23
- AVG Volume (30 Days)
- EVTL 976.1K
- LXRX 2.3M
- Earning Date
- EVTL 08-05-2025
- LXRX 08-06-2025
- Dividend Yield
- EVTL N/A
- LXRX N/A
- EPS Growth
- EVTL N/A
- LXRX N/A
- EPS
- EVTL N/A
- LXRX N/A
- Revenue
- EVTL N/A
- LXRX $58,432,000.00
- Revenue This Year
- EVTL N/A
- LXRX N/A
- Revenue Next Year
- EVTL N/A
- LXRX N/A
- P/E Ratio
- EVTL N/A
- LXRX N/A
- Revenue Growth
- EVTL N/A
- LXRX 1504.83
- 52 Week Low
- EVTL $2.76
- LXRX $0.28
- 52 Week High
- EVTL $15.99
- LXRX $2.18
- Technical
- Relative Strength Index (RSI)
- EVTL 41.55
- LXRX 52.33
- Support Level
- EVTL $4.90
- LXRX $1.10
- Resistance Level
- EVTL $5.17
- LXRX $1.23
- Average True Range (ATR)
- EVTL 0.29
- LXRX 0.06
- MACD
- EVTL 0.00
- LXRX -0.01
- Stochastic Oscillator
- EVTL 35.71
- LXRX 55.45
About EVTL Vertical Aerospace Ltd.
Vertical Aerospace Ltd is engaged in making air travel personal, on-demand, and carbon-free. The company is a world-wide aerospace and technology company that is pioneering electric aviation, focused on designing, manufacturing, and selling a zero operating emission eVTOL aircraft for use in the AAM market, using the technology from the aerospace, automotive, and energy industries. The VX4, Vertical's flagship aircraft, is a piloted electric vertical take-off and landing (eVTOL) vehicle capable of carrying four passengers. The Group operates as a single operating segment and one reporting segment, being the development and commercialization of eVTOL technology.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.